Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience

10.1016/j.clml.2017.07.075 ◽

2017 ◽

Vol 17 ◽

pp. S288-S289 ◽

Cited By ~ 1

Author(s):

Pankit Vachhani ◽

Raed Al Yacoub ◽

Austin Miller ◽

Tara Cronin ◽

Evelena Ontiveros ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Single Center ◽

132 RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE

Leukemia Research ◽

10.1016/s0145-2126(15)30133-8 ◽

2015 ◽

Vol 39 ◽

pp. S67-S68 ◽

Cited By ~ 1

Author(s):

F. Pavesi ◽

C. Messina ◽

M. Carrabba ◽

S. Claudiani ◽

E. Sala ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Retrospective Analysis ◽

Myeloid Leukemia ◽

Allogeneic Transplantation ◽

Single Center ◽

Outcomes by number of induction cycles with CPX-351 vs 7+3 chemotherapy in older adults with newly diagnosed, high-risk/secondary acute myeloid leukemia (sAML).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.7040 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7040-7040

Author(s):

Tara L. Lin ◽

Bruno C. Medeiros ◽

Geoffrey L. Uy ◽

Laura Fugal Newell ◽

Ellen K. Ritchie ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study

10.1016/s2152-2650(21)01811-5 ◽

2021 ◽

Vol 21 ◽

pp. S350

Author(s):

Guillermo Garcia-Manero ◽

Andrew H. Wei ◽

Kimmo Porkka ◽

Steve Knapper ◽

Elie Traer ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Phase 1 ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Phase 1 Study ◽

Very High ◽

Overall Survival (OS) by Outpatient versus Inpatient Consolidation in a Phase 3 Study of CPX-351 versus 7+3 in Older Adults with Newly Diagnosed, High-Risk Acute Myeloid Leukemia (AML)

10.1016/j.clml.2017.07.073 ◽

2017 ◽

Vol 17 ◽

pp. S287

Author(s):

Jonathan Kolitz ◽

Stephen Strickland ◽

Jorge Cortes ◽

Donna Hogge ◽

Jeffrey Lancet ◽

...

Keyword(s):

Older Adults ◽

Overall Survival ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Phase 3 ◽

Impact of intensive chemotherapy versus supportive care on quality of life (QOL) of older adults with newly diagnosed acute myeloid leukemia (AML)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8187 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8187-8187

Author(s):

M. Leach ◽

S. M. H. Alibhai ◽

M. D. Minden ◽

V. Gupta ◽

A. Schattner ◽

...

Keyword(s):

Quality Of Life ◽

Older Adults ◽

Acute Myeloid Leukemia ◽

Supportive Care ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Hypomethylating agents use in acute myeloid leukemia: A single-center experience

Indian Journal of Medical and Paediatric Oncology ◽

10.4103/ijmpo.ijmpo_155_19 ◽

2020 ◽

Vol 41 (2) ◽

pp. 202

Author(s):

SanthoshKumar Devdas ◽

SravanKumar Bodepudi ◽

VinayakV Maka ◽

Rasmi Palassery ◽

SumathiS Hiregoudar ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Hypomethylating Agents ◽

Single Center ◽

FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)

Hematology Transfusion and Cell Therapy ◽

10.1016/j.htct.2020.10.257 ◽

2020 ◽

Vol 42 ◽

pp. 152

Author(s):

J.E. Lancet ◽

T.L. Lin ◽

D. Hogge ◽

S.R. Solomon ◽

G.J. Schiller ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Phase 3 ◽

Poster: MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study

10.1016/s2152-2650(21)01447-6 ◽

2021 ◽

Vol 21 ◽

pp. S230

Author(s):

Guillermo Garcia-Manero ◽

Andrew H. Wei ◽

Kimmo Porkka ◽

Steve Knapper ◽

Elie Traer ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Phase 1 ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Phase 1 Study ◽

Very High ◽

Outcomes in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML) Who Achieved Remission with CPX-351 Versus 7+3 Induction: Exploratory Analysis of a Phase 3 Study

10.1016/j.clml.2019.07.068 ◽

2019 ◽

Vol 19 ◽

pp. S206-S207 ◽

Cited By ~ 1

Author(s):

Stefan Faderl ◽

Jorge E. Cortes ◽

Ellen K. Ritchie ◽

Robert J. Ryan ◽

Michael Chiarella ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Exploratory Analysis ◽

Newly Diagnosed ◽

Phase 3 ◽